A carregar...
Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis
Sorafenib and lenvatinib, as molecular‐targeted agents, constitute effective primary treatment options for advanced hepatocellular carcinoma (HCC). However, the choice of optimal primary treatment agent remains controversial. Here, we aimed to assess the respective outcomes between these agents as p...
Na minha lista:
| Publicado no: | Hepatol Commun |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395064/ https://ncbi.nlm.nih.gov/pubmed/32766480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1535 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|